Copyright
©The Author(s) 2020.
World J Clin Cases. Nov 6, 2020; 8(21): 5116-5127
Published online Nov 6, 2020. doi: 10.12998/wjcc.v8.i21.5116
Published online Nov 6, 2020. doi: 10.12998/wjcc.v8.i21.5116
Table 3 Treatment characteristics of primary normal size ovarian cancer syndrome and papillary serous ovarian carcinoma, n (%)
Characteristic, patients with data available | NOCS | PSOC | P value |
Initial surgery | 0.892 | ||
Complete | 79 (71.8) | 108 (71.1) | |
Incomplete | 31 (28.2) | 44 (28.9) | |
Operation method | 0.000 | ||
Laparotomy | 49 (44.5) | 112 (73.7) | |
Laparoscopy | 61 (55.5) | 40 (26.3) | |
Residual tumor | 0.136 | ||
Yes | 67 (60.9) | 106 (69.7) | |
No | 43 (39.1) | 46 (30.3) | |
Chemotherapy | 0.000 | ||
Platinum-based | 86 (77.3) | 142 (93.4) | |
Nonplatinum-based | 3 (2.7) | 0 (0.0) | |
Without | 22 (20) | 10 (6.6) | |
Chemotherapy numbers | 0.051 | ||
≥ 6 | 58 (65.2) | 74 (52.1) | |
< 6 | 31 (34.8) | 68 (47.9) |
- Citation: Yu N, Li X, Yang B, Chen J, Wu MF, Wei JC, Li KZ. Clinical characteristics and survival of patients with normal-sized ovarian carcinoma syndrome: Retrospective analysis of a single institution 10-year experiment. World J Clin Cases 2020; 8(21): 5116-5127
- URL: https://www.wjgnet.com/2307-8960/full/v8/i21/5116.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i21.5116